Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Saint Johnsbury VT, Lebanon NH, New York NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase2, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Lake Success NY,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
for
Delirium
Location: Boston MA, The Bronx NY, New York NY, Baltimore MD,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 60+
Code: NCT06192615
Phase3, Recruiting
Supporting Infant Development Through Tummy Time, Positioning, and Limiting Baby Gear
for
Prone Position, Child Development
Location: Memphis TN
Sponsor: University of Tennessee
Sex: All
Age: 0 - 4
Code: NCT05878275
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
Metabolic Effects of Angiotensin-(1-7)
for
Obesity, Insulin Resistance, Hypertension,
Location: Nashville TN
Sponsor: Vanderbilt University
Sex: All
Age: 18 - 60
Code: NCT02646475
Phase1, Recruiting
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 19+
Code: NCT05945875
Phase1, Recruiting
Patient Retrospective Outcomes (PRO)
for
Chronic Pain
Location: The Bronx NY, New Bern NC, Jupiter FL, Vero Beach FL,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01550575
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Moncton, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Location: Nashville TN, Dallas TX, Denver CO, San Diego CA
Sponsor: Acepodia Biotech, Inc.
Sex: All
Age: 18+
Code: NCT06415487
Phase1, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Boston MA, Lake Success NY, New Hyde Park NY,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase2, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Providence RI, New Haven CT, Quebec, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Boston MA, Milford CT, New York NY, Philadelphia PA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase3, Recruiting
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
for
Cardiac Failure, Graft Rejection
Location: New York NY, Pittsburgh PA, Ann Arbor MI, Nashville TN,